alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
1

Comments on the Preliminary Materials for the 

IRIS Toxicological Review of Ethyl tert-Butyl Ether 

(ETBE) and tert-butyl alcohol (tert-butanol) 

IRIS Bimonthly Meeting 

December 12-13, 2013 

The American Petroleum Institute

Russell White, Ph.D.
Comments on the Preliminary

Materials for ETBE and TBA

General

 The scope of the assessments to be conducted, and the 

problem(s) to be addressed are not described in the 

materials released by EPA. Defining these elements are 

important prerequisites to gathering relevant data. 

 Indication of critical studies, the rationale for selection, and 

data quality must be included in Evidence Tables in order to 

meet the Agency’s stated goals for the enhanced IRIS 

process. 

 This information is needed to frame scientific issues, 

identify uncertainties and direct research. 

1220 L Street, NW • Washington, DC 20005-4070 • www.api.org 2
Comments on the Preliminary

Materials for ETBE and TBA

General

 Some aspects of the literature search strategy should be 

improved, notably: 

 review of ECHA’s database of information submitted in 

support of REACH registration of these substances; 

 and consideration of excluded exposure studies and 

environmental fate studies in defining scope and 

problem formulation. 

 Mode of Action (MOA) data should be considered in 

selecting pertinent data for Evidence Tables (e.g. male rat 

kidney effects). 

1220 L Street, NW • Washington, DC 20005-4070 • www.api.org 3
Comments on the Preliminary

Materials for ETBE and TBA

Specific

 Some aspects of the literature search strategy for these 

substances should be improved, notably: 

 inclusion of all studies conducted under the requirements 

of the Clean Air Act, Section 211(b);

 consideration of the relationship of tert-Butanol data to 

evaluation of ETBE systemic toxicity; 

 Tumor promotion data for ETBE should be removed from 

the Evidence Tables and Exposure Response-Arrays, since 

well conducted chronic rodent bioassays have been reported 

for this substance. 

1220 L Street, NW • Washington, DC 20005-4070 • www.api.org 4
Comments on the Preliminary

Materials for ETBE and TBA

Specific 

 EPA should consider the current status of these substances 

as fuel additives in defining the scope and formulating 

problems to be addressed

 The Maltoni et al., 1999 study of (ETBE) should be 

evaluated in light of the National Toxicology Program’s 

(NTP) subsequent review, and any assessment of data from 

this study should reflect the findings of NTP’s review. 

1220 L Street, NW • Washington, DC 20005-4070 • www.api.org 5
Comments on the Preliminary

Materials for ETBE and TBA

Thank You for Your Attention 

Any Questions?

1220 L Street, NW • Washington, DC 20005-4070 • www.api.org 6
#### The People of the State of New York, Respondent, v *777Billy Ray Littlejohn, Appellant.

Appeal by the defendant from a judgment of the County Court, Dutchess County (King, J.), rendered November 8, 1989, convicting him of criminal sale of a controlled substance in the third degree, criminal possession of a controlled substance in the third degree (three counts), and bail jumping in the second degree, upon a jury verdict, and sentencing him to an indeterminate term of 8 to 24 years imprisonment for criminal sale of a controlled substance in the third degree, to run concurrently with three consecutive indeterminate terms of 8 to 24 years imprisonment for criminal possession of a controlled substance in the third degree (three counts), all to run consecutively to an indeterminate term of *IV3*to 4 years imprisonment for bail jumping in the second degree.

Ordered that the judgment is affirmed.

Viewing the evidence in the light most favorable to the prosecution *(see, People v Contes,*60 NY2d 620), we find that it was legally sufficient to establish the defendant’s guilt beyond a reasonable doubt. Moreover, upon the exercise of our factual review power, we are satisfied that the verdict of guilt was not against the weight of the evidence *(see,*CPL 470.15 [5]).

Furthermore, the trial court properly denied the defendant’s request for substitution of counsel *(see, People v Sawyer,*57 NY2d 12, *cert denied*459 US 1178; *People v Arroyave,*49 NY2d 264). The defendant’s request was made after the commencement of trial *(People v Arroyave, supra,*at 271-272), and he did not demonstrate sufficient good cause to warrant substitution *(see, People v Sawyer, supra,*at 19; *People v Rodriguez,*126 AD2d 580).

Similarly, the sentence imposed upon the defendant was not excessive *(see, People v Suitte,*90 AD2d 80). The imposition of consecutive sentences for each conviction of criminal possession of a controlled substance in the third degree and for bail jumping in the second degree was appropriate under the circumstances of this case, as the offenses charged constituted separate and distinct acts *(see,*Penal Law § 70.25; *People v Brathwaite,*63 NY2d 839). Moreover, there was no impropriety in the imposition of an aggregate maximum term of 76 years. Since the defendant was convicted of four crimes, at least one of which was a class B felony, pursuant to Penal Law § 70.30 (1) (c) (i), this aggregate maximum term must be deemed 30 years *(see, People v Moore,*61 NY2d 575; *People v Bachman,*158 AD2d 930). Sullivan, J. P., Fiber, Miller and Ritter, JJ., concur.
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3840 Introduced in House (IH)]

103d CONGRESS
  2d Session
                                H. R. 3840

To designate the Federal building and United States courthouse located 
 at 100 East Houston Street in Marshall, Texas, as the ``Sam B. Hall, 
          Jr. Federal Building and United States Courthouse''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 10, 1994

 Mr. Chapman introduced the following bill; which was referred to the 
              Committee on Public Works and Transportation

_______________________________________________________________________

                                 A BILL

 
To designate the Federal building and United States courthouse located 
 at 100 East Houston Street in Marshall, Texas, as the ``Sam B. Hall, 
          Jr. Federal Building and United States Courthouse''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION.

    The Federal building located at 100 East Houston Street in 
Marshall, Texas, shall be known and designated as the ``Sam B. Hall, 
Jr. Federal Building and United States Courthouse''.

SEC. 2. REFERENCES.

    Any reference in a law, map, regulation, document, paper, or other 
record of the United States to the Federal building and United States 
courthouse referred to in section 1 shall be deemed to be a reference 
to the ``Sam B. Hall, Jr. Federal Building and United States 
Courthouse''.

                                 <all>
```
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Kenneth M.
Roessler, President and Chief Executive Officer of BWAY Intermediate Company, Inc. (the Company) and Michael B. Clauer, Executive Vice-President and Chief Financial Officer of the Company, certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:



| | (1) | The quarterly report on Form 10-Q of the Company for the quarter ended March 31, 2011 (the Report) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                                                         
|---------------------------------------------------------
|Dated: May 13, 2011                                      
|                                                         
|/s/ Kenneth M. Roessler                                  
|Kenneth M. Roessler President and
Chief Executive Officer
|                                                         
|/s/ Michael B.
Clauer                                    
|Michael B. Clauer                                        
|Executive Vice President and Chief
Financial Officer
Exhibit 32.1

Certification of
Principal Executive OfficerPursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

In
connection with the Quarterly Report of Phoenix Agri Enterprises, Inc. (the “Company”) on Form 10-Q for the period
ended January 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Benjamin
Chen, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.

|Date: March 21, 2011 |                                                         | /s/ Benjamin Chen
|-------------------- | ------------------------------------------------------- | -----------------
|                     | Name: Benjamin Chen
        Principal Executive Officer
THIS OPINION HAS NO PRECEDENTIAL VALUE. IT SHOULD NOT BE CITED OR RELIED ON AS PRECEDENT IN ANY P ROCEEDING EXCEPT AS PROVIDED BY RULE 268(D)(2), SC ACR.

THE STATE OF SOUTH C AROLINA In The Supreme Court

H. Hughes Andrews, Petitioner,

v.
Quentin S. Broom, Jr., Respondent.

Appellate Case No. 2022

- 000285

ON WRIT OF CERTIORARI TO THE COURT OF APPEALS

Appeal f rom Spartanburg County J. Mark Hayes II, Circuit Court Judge

M emorandum O pinion No. 2024 -MO- 001 Heard December 12, 2023 – Filed January 17, 2024

DISMISSED AS IMPROVIDENTLY GRANTED

Rodney F. Pillsbury, of Pillsbury Law Firm, LLC , of Greenville
, for Petitioner.

Matthew Terry Richardson, of Wyche, PA ; Whitney Boykin Harrison, of McGowan
, Hood & Felder
, both of Columbia ; and James Edward Cox Jr., of Wyche, PA
, of Greenville
, all for Respondent

.PER CURIAM : 

### We granted a writ of certiorari to review the court of appeals' decision in Andrews v. Broom , Op. No. 2022

- UP

- 022 (S.C. Ct. App. filed Feb. 9, 2022)

. We now dismiss the writ as improvidently granted.

DISMISSED AS IMPROVIDENTLY GRANTED

. BEATTY, C.J., KITTREDGE, FEW, JAMES and HILL, JJ., concur.
In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02-19-00092-CR

JAMES RAY GREGORY, Appellant

V.

THE STATE OF TEXAS

§

§

§

§

§

On Appeal from the 372nd District Court

of Tarrant County (1503764D)

January 14, 2021

Memorandum Opinion by Justice Wallach

(nfp)

JUDGMENT

This court has considered the record on appeal in this case and holds that there 

was no error in the trial court’s judgment. It is ordered that the judgment of the trial 

court is affirmed.

SECOND DISTRICT COURT OF APPEALS

By _/s/ Mike Wallach___________________

 Justice Mike Wallach
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          APR-30-1997
<PERIOD-START>                             MAY-01-1996
<PERIOD-END>                               APR-30-1997
<EXCHANGE-RATE>                                      1
<CASH>                                           8,508
<SECURITIES>                                         0
<RECEIVABLES>                                   49,844
<ALLOWANCES>                                         0
<INVENTORY>                                     60,574
<CURRENT-ASSETS>                               125,352
<PP&E>                                          69,628
<DEPRECIATION>                                (20,457)
<TOTAL-ASSETS>                                 215,297
<CURRENT-LIABILITIES>                           63,372
<BONDS>                                         11,282
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           425
<OTHER-SE>                                     138,358
<TOTAL-LIABILITY-AND-EQUITY>                   215,297
<SALES>                                        292,394
<TOTAL-REVENUES>                               292,394
<CGS>                                          238,625
<TOTAL-COSTS>                                  268,817
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 620
<INCOME-PRETAX>                                 22,957
<INCOME-TAX>                                     8,436
<INCOME-CONTINUING>                             14,521
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    14,521
<EPS-PRIMARY>                                     0.35
<EPS-DILUTED>                                     0.35
        

</TABLE>
exh_101.htm


EXHIBIT 10.1


 



	Yoav Sibony 	September 30, 2013





Duvall, WA







Dear Yoav;







I am pleased to make you a tentative offer of employment for the position of Vice President Global Sales for Harvard Bioscience, Inc. This position will report directly to me. Your weekly salary will be $3,365.38, paid as earned and which is the yearly equivalent of $175,000.00. In addition to base salary, you will be given 50,000 stock options that vest in equal installments over four years from the initial grant date. The initial grant date will be the eleventh trading day after the HART spinoff and the strike price will be the average of the ten preceding trading days. You are eligible for an annual bonus up to 35% of base salary upon attainment of goals set by the CEO. A car allowance of $500 per month and business mileage reimbursement is also included. Your employment will begin on October 28, 2013 or sooner if you are able. Please note this offer is contingent on a review of the results of a background screening and a drug test.







Harvard Bioscience offers a competitive benefits package including major medical, dental, vision, life insurance and a retirement plan with company match. You will also earn three weeks of vacation and six personal days. Additional details on our benefit offerings will be provided on acceptance of this offer.







As is standard with positions such as this, you must sign an agreement to protect and hold confidential all proprietary and confidential information regarding Harvard Bioscience, any of its affiliates, its customers and employees both during and after the period of your employment. You must also acknowledge that any inventions, discoveries, processes and/or improvements developed by you in the course of your employment or in any way resulting from your employment with us remain the property of the Company exclusively.







All offers of employment are on an at-will basis which means that either you or we may terminate our employment relationship at any time with or without cause.







Yoav, we are excited by the prospect of you joining us. Based on you practical and relevant experience, we believe you will bring much needed strategic sales skills to the organization. Please acknowledge your acceptance of this tentative offer of employment by signing and returning a copy of this letter to me. At that point, Frank Aubuchon will provide you with the necessary paperwork for completing your background check and drug screening.


 



	/s/ Jeffrey A. Duchemin, CEO	9/30/13	 	/s/ Yoav Sibony 	9/30/13	 
	Jeffrey A. Duchemin, CEO 	Date	 	Yoav Sibony	Date	 















84 October Hill Road • Holliston, Massachusetts 01746-1388


Phone: 508-893-8999 • Fax: 508-429-5732


www.harvardapparatus.com • www.harvardbioscience.com
#### Eduardo Pedro PELLON, Appellant, v. STATE of Florida, Appellee.

No. 43058.

Supreme Court of Florida.

July 12, 1973.

Appeal dismissed, sua sponte.

CARLTON, C. J., and ROBERTS, ERVIN, ADKINS, BOYD and McCAIN, JJ., concur.
Exhibit 32.1





STATEMENT FURNISHED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the accompanying Quarterly Report on Form 10-Q of China Hefeng Rescue Equipment, Inc.(the "Company") for the quarter ended June 30, 2012:





I, Zhengyuan Yan , Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:





1.            Such Quarterly Report on Form 10-Q for the quarter ending June 30, 2012, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.            The information contained in such Quarterly Report on Form 10-Q for the quarter ending June 30, 2012, fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date: August 17, 2012
By:
/s/ Zhengyuan YanZhengyuan YanChief Executive Officer(Principal Executive Officer)
FILED: May 27, 1997 PUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 94-1219

Catherine W. Griffin, Plaintiff - Appellant,
versus Medtronic, Incorporated, Defendant - Appellee.

ORDER
On April 30, 1996, this court affirmed in part and reversed in part the district court's opinion granting Medtronic, Inc.'s motion for summary judgment. See Griffin v. Medtronic, Inc. , 82 F.3d 79 (4th Cir. 1996). The Supreme Court granted certiorari and vacated this court's judgment for further consideration in light of Medtronic, Inc. v. Lohr , 518 U.S. ___, 116 S. Ct. 2240 (1996). See Griffin v. Medtronic, Inc. , ___ U.S. ___, 117 S. Ct. 939 (1997).Expressing no opinion on the ultimate decision, and after reviewing Lohr and, as well, our decision in Duvall v. Bristol-MyersSquibb Co. , 103 F.3d 324 (4th Cir. 1996), another case remanded tous in view of Lohr , we think it better to remand as to each of the five counts in the Griffin complaint, as named on page two of our slip opinion in this case, and to require their reconsideration under Lohr and Duvall , supra . It is so ORDERED. Entered at the direction of Senior Judge Michael, with the concurrence of Judge Widener and Judge Motz.

______________________________ CLERK
# Fourth Court of Appeals

San Antonio, Texas

February 27, 2017

No. 04

- 16

- 00622

- CR

Antonio TORRES, Appellant

v.

The STATE of Texas, Appellee

From the 186th Judicial D istrict Court, Bexar County, Texas

Trial Court No. 2014CR0934 Honorable Jefferson Moore, Judge Presiding



### O R D E R

Appellant’s brief is due March 10, 2017. On February 13, 2017, appellant’s court

appointed attorney filed a motion asking this court to recalculate the due date for the brief

because the repor ter’s record is not complete. Attached to the motion is a copy of a February 13

2017

, request sent to the court reporter responsible for preparing, certifying, and filing the reporter’s record, Ms. Debra Doolittle

, designating the necessary supplemen tal records.

The motion is GRANTED. Ms. Doolittle is hereby ORDERED to file the reporter’s records requested by appellant no later than March 29 , 2017 . Appellant’s brief is due thirty days after the record is complete.

________________________________ _ Sandee Bryan Marion, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 27th day of February, 2017

.

___________________ ________________ Keith E. Hottle

Clerk of Court
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 535 Introduced in Senate (IS)]

113th CONGRESS
  1st Session
                                 S. 535

  To require a study and report by the Small Business Administration 
 regarding the costs to small business concerns of Federal regulations.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 12, 2013

Mr. Rubio (for himself, Mr. Risch, Mr. Enzi, Mr. Johnson of Wisconsin, 
   Mrs. Fischer, Mr. Vitter, Mr. Paul, and Mr. Scott) introduced the 
 following bill; which was read twice and referred to the Committee on 
                  Small Business and Entrepreneurship

_______________________________________________________________________

                                 A BILL

 
  To require a study and report by the Small Business Administration 
 regarding the costs to small business concerns of Federal regulations.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Regulation Costs to Small Business 
Act''.

SEC. 2. SMALL BUSINESS ADMINISTRATION STUDY ON THE COST OF FEDERAL 
              REGULATIONS.

    (a) In General.--The Administrator shall conduct an annual study of 
the total costs to small business concerns of Federal regulations.
    (b) Requirement.--In conducting the study required under subsection 
(a), the Administrator shall use a methodology that is substantially 
similar to the methodology used in conducting the study described in 
the report entitled ``The Impact of Regulatory Costs on Small Firms'' 
(September 2010), prepared on behalf of the Office of Advocacy of the 
Administration.
    (c) Report.--Not later than 1 year after the date of enactment of 
this Act, and annually thereafter, the Administrator shall submit to 
Congress a report on the findings of the study conducted under 
subsection (a), which shall include an estimate of the total annual 
costs of Federal regulations to small business concerns, by agency, as 
such term is defined in section 551 of title 5, United States Code.
    (d) Funding.--
            (1) In general.--The Administration shall carry out this 
        section using unobligated funds otherwise made available to the 
        Administration.
            (2) Sense of congress regarding funding.--It is the Sense 
        of Congress that no additional funds should be made available 
        to the Administration to carry out this Act.

SEC. 3. DEFINITIONS.

    In this Act--
            (1) the terms ``Administration'' and ``Administrator'' mean 
        the Small Business Administration and the Administrator 
        thereof, respectively; and
            (2) the term ``small business concern'' has the same 
        meaning as in section 3 of the Small Business Act (15 U.S.C. 
        632).
                                 <all>
```